Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-06-05 Liang Howard CFO & Chief Strategy Officer Grant or award · Share Option (Right to Buy) +558,285 558,285
2019-06-05 Chen Timothy Yung-Cheng Director Grant or award · Share Option (Right to Buy) +64,610 64,610
2019-06-05 Wu Xiaobin President & GM China Grant or award +433,472 1,505,956
2019-06-05 Wu Xiaobin President & GM China Grant or award · Share Option (Right to Buy) +797,550 797,550
2019-06-05 su Jingshyh S Director Grant or award · Share Option (Right to Buy) +64,610 64,610
2019-06-05 Glazer Donald W. Director Grant or award · Share Option (Right to Buy) +64,610 64,610
2019-06-05 Malley Thomas Director Grant or award · Share Option (Right to Buy) +64,610 64,610
2019-06-05 OYLER JOHN Chief Executive Officer Grant or award · Share Option (Right to Buy) +2,193,282 2,193,282
2019-06-05 BAKER BROS. ADVISORS LP Director Grant or award · Shares Option (Right to Buy) +129,220 129,220
2019-05-21 Huang Jane CMO, Hematology Exercise or conversion +2,200 $45.31 $100K 2,200
2019-05-21 Huang Jane CMO, Hematology Sale −2,200 $130.06 $286K 0
2019-05-21 Huang Jane CMO, Hematology Exercise or conversion · Share Option (Right to Buy) +28,600 947,965
2019-05-21 Liang Howard CFO & Chief Strategy Officer Exercise or conversion +23,200 $6.50 $151K 23,200
2019-05-21 Liang Howard CFO & Chief Strategy Officer Sale −23,200 $130.21 $3.0M 0
2019-05-21 Liang Howard CFO & Chief Strategy Officer Exercise or conversion · Share Option (Right to Buy) +301,600 4,120,000
2019-05-20 Huang Jane CMO, Hematology Exercise or conversion +300 $45.31 $14K 300
2019-05-20 Huang Jane CMO, Hematology Sale −300 $130.12 $39K 0
2019-05-20 Huang Jane CMO, Hematology Exercise or conversion · Share Option (Right to Buy) +3,900 976,565
2019-05-13 Glazer Donald W. Director Sale −15,027 $125.11 $1.9M 0
2019-05-06 Liang Howard CFO & Chief Strategy Officer Exercise or conversion +1,800 $6.50 $12K 1,800

Page 102 of 123 · 2,455 trades